High-dose melphalan is not associated with extramedullary relapses in high-risk multiple myeloma

J Clin Oncol. 1993 Sep;11(9):1832. doi: 10.1200/JCO.1993.11.9.1832.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Female
  • Humans
  • Male
  • Melphalan / administration & dosage*
  • Melphalan / therapeutic use
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / genetics
  • Mutation
  • Recurrence

Substances

  • Melphalan